Pharmafile Logo

Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech

October 8, 2018 | Med Tech, Pharma, Wilmington Healthcare 

Healthcare intelligence provider Wilmington Healthcare has introduced a host of new features to its unique digital learning platform, which enables pharma and medtech sales staff to keep abreast of NHS developments, policies and constraints.

- PMLiVE
PRESS RELEASE
   

4th October 2018
     

Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech
    

Healthcare intelligence provider Wilmington Healthcare has introduced a host of new features to its unique digital learning platform, which enables pharma and medtech sales staff to keep abreast of NHS developments, policies and constraints.   

Powered by Wellards, the Digital Learning Academy has refreshed, in-depth content and a range of new interactive online learning courses with videos, which can now be accessed on any device from a desktop to a smartphone.   New courses on offer include: “What do you need to know about NHS England’s plan for ICSs and ICOs?”, which addresses how integrated care systems and integrated care organisations will start to replace Sustainability and Transformation Partnerships (STPs). 

The platform also has an improved reporting system for managers to track the progress of their staff. This makes it easier for team leaders and training managers to track and monitor users, and oversee compliance and training.   It also means that if users need to exit a course or exam at any point, the platform will remember where they left and allow them to re-join at the same place, saving them time.

Another change is that the Digital Learning Academy’s hospital and theatre access courses are now accredited and accepted by IntelliCentrics Secure and Who Are You Ltd as well as being Medical Industry Accredited (MIA).

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Our Digital Learning Academy plays a critical role in helping pharma and medtech sales teams keep abreast of the latest developments in the NHS and ensuring they remain compliant with the industry code and data protection legislation.  

“The changes that we have introduced will further enhance the learning experience for our users by offering them a greater range of courses. It will also make it easier for them to learn anywhere, anytime, and for their managers to track progress.”   For more details on the Digital Learning Academy, visit: https://wilmingtonhealthcare.com/what-we-do/education-and-training/digital-learning-academy/       

Ends   

Notes to Editors
    

For more information, please contact:
 Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com     

About Wilmington Healthcare and Wilmington plc
   
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com

Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.   

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...